BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID
Authorization expands use of bezisterim in a Phase 2, placebo-controlled, multicenter trial assessing bezisterim’s impact on neurological symptoms associated with long COVID Key milestone reached ...
Daily14m
USFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults
Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY ...
AbbVie Submits BLA To FDA For Telisotuzumab Vedotin In Previously Treated Non-Small Cell Lung Cancer
AbbVie (ABBV) announced submission of a Biologics License Application or BLA to the U.S. Food and Drug Administration for accelerated ...
Old newspaper boxes are being used to distribute the overdose reversal drug Narcan
Old newspaper boxes are being repurposed into containers that distribute Narcan, an emergency treatment to reverse drug ...
Bristol-Myers Squibb Likely To Revalue Higher Following New Drug Approval
Bristol-Myers Squibb's stock is set to rise with FDA approvals, acquisitions, and a strong oncology portfolio, despite ...
The Daily News Online2h
Lactaid milk recalled in several states, including N.Y.
Some units of Lactaid milk are being recalled in several states, including in New York, according to the U.S. Food and Drug Administration (FDA).
Food Safety News3h
FDA steps up import enforcement on certain cheese, seafood, coconut and more
The Food and Drug Administration continues using import alerts to enforce U.S. food safety regulations for food from foreign ...
WCPO Cincinnati3h
FDA approves first new medication to treat schizophrenia in more than 30 years
People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...
Pork Product Recall Sparks Warning to Customers
The fried pork skin products were recalled due to the presence of soy, one of the major food allergens defined by the FDA.
US FDA Clears First One-Year Continuous Glucose Monitoring Sensor; Can Help Manage Diabetes Better
The US Food and Drug Administration has cleared the Eversense 365 - an implanted continuous glucose monitoring system that ...
In a Victory for the Free Market, FDA Approves New Schizophrenia Drug
Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...
health.wusf.usf.edu6h
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...